Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Researcher

Biomedicine · China · 2025-04-09

Processing Time
169 days
Decision Date
2025-04-09
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research in the development of pharmacokinetics (PK) and pharmacodynamics (PD) studies, specifically focusing on the targeted delivery of anti-tumor and antimicrobial medications. This work involves synthesizing bioactive polymers, spatial metabolomics, and protein engineering to improve therapeutic efficacy. The endeavor aims to advance precision medications that reduce side effects for challenging diseases.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical health issues and promotes societal resilience through the development of anti-tumor and antimicrobial medications.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to a decade of specialization, a strong publication record, and leadership in federally funded research.

3 Balance of Factors Met

It was determined beneficial to waive the labor certification requirement given the petitioner's international recognition and the clinical impact of their precision medicine research.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 15 peer-reviewed journal articles and over 500 citations, placing them in the top 5% of their field. Evidence included at least 8 completed peer reviews and invited presentations at international conferences. The case successfully satisfied all three Dhanasar prongs by demonstrating significant contributions to NSF and NIH-funded research.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Conference Presentations
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
Maryland 350 days 2025-06-13
The petitioner proposes to continue her research in pharmacology, specifically focusing on assessing the pharmacokinetic properties of novel medications using in vitro and in vivo models to minimize adverse drug effects and maximize efficacy for conditions such as diabetes, Alzheimer’s, and cancer.
View Case

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) rfe approved
North Carolina 111 days 2025-02-08
The petitioner proposes to improve existing therapies by applying advanced pharmaceutical principles to commercialize biopharmaceuticals and pharmaceuticals. The work focuses on developing innovative drug solubility enhancement methods and non-invasive oral drug delivery systems to treat serious diseases like cancer, AIDS, and kidney failure.
View Case

Associate Professor

Pharmaceuticals · Saudi Arabia

WeGreened EB-2 (NIW) approved
505 days 2025-05-16
The petitioner proposes to continue research in pharmaceutics, specifically focusing on drug nano-delivery systems and the development of smart, sustainable alternative drug dosage forms. This work utilizes pharmaceutical technology to improve the deliverability, targetability, efficacy, and safety of drugs. The intended impact is to address critical needs in drug formulation and patient care within the United States.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-09.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 169 days
Criteria Met 3 / 3
Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist